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ABSTRACT
Background: Angiogenesis in the alveolar septa is thought be a critical factor in pulmonary emphysema.
Angiomotin-like protein 1 (AmotL1) is involved in angiogenesis via regulating endothelial cell function. How-
ever, the role of AmotL1 in the pathogenesis of pulmonary emphysema has not been elucidated. The objective
of this study is to evaluate the expression of AmotL1 in lung tissues from a murine model with emphysema, as
well as from patients with chronic obstructive pulmonary disease (COPD). Furthermore, we analyzed the regu-
lation of AmotL1 expression by TNF-α and IFN-γ in endothelial cells in vitro.
Methods: Nrf2 knockout mice were exposed to cigarette smoke (CS) for 4 weeks, and the down-regulated
genes affecting vascularity in the whole lung were identified by microarray analysis. This analysis revealed that
the mRNA expression of AmotL1 decreased in response to CS when compared with air exposure. To confirm
the protein levels that were indicated in the microarray data, we determined the expression of AmotL1 in lung
tissues obtained from patients with COPD and also determined the expression of AmotL1, NFκB and IκBα in
cultured normal human lung microvascular endothelial cells (HLMVECs) that were stimulated by TNF-α and
IFN-γ.
Results: We found that the number of AmotL1-positive vessels decreased in the emphysema lungs compared
with the normal and bronchial asthmatic lungs. IFN-γ pretreatment diminished the TNF-α-induced AmotL1 in
the cultured HLMVECs by blocking the degradation of IκBα.
Conclusions: These results suggested that IFN-γ exhibits anti-angiogenesis effects by regulating the expres-
sion of TNF-α-induced AmotL1 via NFκB in emphysema lungs.
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INTRODUCTION
Chronic obstructive pulmonary disease (COPD),
which is primarily a smoking-related inflammatory
lung disease, can be defined by chronic airflow limita-
tion confirmed by spirometry.1 Tumor necrosis factor
(TNF)-α and interferon (IFN)-γ levels are signifi-
cantly elevated compared with healthy smokers and
non-smokers, and these cytokines are apparently in-
volved in the pathogenesis of COPD as primary me-
diators that drive the inflammation that is characteris-
tic of COPD.2-4 Angiogenesis has also been sug-
gested to be one of the critical factors in the patho-
genesis of pulmonary emphysema. Based on the ob-
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servation that the alveolar septa in centrilobular em-
physema are remarkably thin and avascular, Liebow
theorized that a reduced blood supply from small pre-
capillary blood vessels might induce the disappear-
ance of the alveolar septa.5 This hypothesis for the
pathogenesis of emphysema has been supported by
the results of a recent study in which the expression
of both vascular endothelial growth factor (VEGF)
and its receptors were decreased in the lung tissues
of emphysema patients.6,7 However, the effects of
TNF-α and IFN-γ on angiogenesis in emphysema
have not been fully elucidated. We hypothesize that
increased levels of TNF-α and IFN-γ will interact in
lung endothelial cells and result in hypovascularity.
In the present study, we demonstrated that the
mRNA and protein expression levels of angiomotin-
like protein 1 (AmotL1) in whole lungs were de-
creased in cigarette smoke (CS)-exposed NF-E2 re-
lated factor 2 (Nrf2) knockout (Nrf2−−) mice com-
pared with those in the Nrf2−− mice without CS expo-
sure. AmotL1 is involved in angiogenesis via the
regulation of endothelial cell function. Amot, together
with AmotL1 and AmotL2, belongs to a novel protein
family that is characterized by a conserved glutamine-
rich domain.8,9 AmotL1 was initially cloned from a
mouse pancreatic islet endothelial cell line as a tight
junction-enriched and associated protein.10,11 The bio-
logical function of AmotL1 has been reported to regu-
late sprouting angiogenesis by influencing tip cell mi-
gration and controlling the cell-cell junctions of stalk
cells.12 We also identified the promoter segment for
the AmotL1 gene in normal human lung microvascu-
lar endothelial cells (HLMVECs) as the -387 to -372
region upstream from the translation initiation codon.
NFκB was found to bind to this AmotL1 promoter re-
gion. In vitro investigations using HLMVECs have re-
vealed that TNF-α induced AmotL1 expression via
NFκB, whereas TNF-α-induced IκBα degradation is
completely suppressed in HLMVECs by IFN-γ treat-
ment. These studies demonstrate the role of a novel
angiogenic molecule, AmotL1, which is regulated by
TNF-α and IFN-γ, in pulmonary emphysema.
METHODS
ANIMAL CARE AND CIGARETTE SMOKE EXPO-
SURE
All of the animal protocols used in this study were ap-
proved by the National Institute of Environment
Health Sciences’ Animal Care and Use Committee
and followed the Helsinki Convention standards for
the use and care of animals. The experimental proce-
dures were approved by the institutional animal care
and use committees at Iwate Medical University in
accordance with the university’s animal experiments
regulations. The Nrf2−− mice, which were back-
crossed >20 times into a C57BL6J background, were
purchased from RIKEN BioResource Center (Ibaraki,
Japan). The mice were genotyped for Nrf2 status by
the polymerase chain reaction (PCR) amplification of
genomic DNA, which had been extracted from the
blood as previously described.13 All of the mice used
in this study were aged 9-10 -weeks and were main-
tained under specific pathogen-free conditions. The
mice were divided into 2 groups (n = 11 per group):
control Nrf2−− mice and experimental Nrf2−− mice.
The control groups were kept in a filtered air environ-
ment, and the CS-exposed groups were subjected to
CS exposure, which was performed (5 hours per day,
5 daysweek for up to 4 weeks) by burning 3R4F
cigarettes (purchased from the Tobacco Research In-
stitute, University of Kentucky, KY, USA) using a
smoking apparatus (SIC-CS type, SG-200, Shibata Ka-
gaku, Saitama, Japan). Each smoldering cigarette was
puffed for 2 seconds at 5 puffs (175 ml)min, with a
flow rate of 5375.5 mlmin diluted with compressed
air (3% final concentration), and then air flow (1700
mlmin) dispersed the cigarette smoke into the
sealed mouse container (3600 cm3).
LUNG HISTOLOGY AND QUANTIFICATION OF
EMPHYSEMA IN THE EXPERIMENTAL MOUSE
MODEL
The tracheas and lungs of the anesthetized mice
were terminally removed and inflated with 4% parafor-
maldehyde in PBS to a pressure of 12 cm H2O. The
tissues were then embedded in paraffin, and 5-μm-
thick sections were stained with hematoxylin and eo-
sin (HE). Air space enlargement was quantified with
the mean linear intercept in randomly selected fields
of tissue sections. The mean linear intercept, as a
measure of interalveolar septal wall distance, was
measured using light microscopy at a magnification
of 100×. The mean linear intercept was obtained by
dividing the length of a line drawn across the lung
section by the total number of intercepts encountered
in 36 lines per mouse lung, as described previ-
ously.14,15
COLLECTION AND ANALYSIS OF BRONCHOAL-
VEOLAR LAVAGE FLUID OF THE EXPERIMEN-
TAL MICE
Bronchoalveolar lavage (BAL) was performed as de-
scribed previously.16 All BAL fluid (1 ml of saline so-
lution 2 separate times) was collected, and BAL cells
were counted. Cell types were identified based on
morphological criteria. The absolute numbers of each
cell type were calculated. One hundred thousand vi-
able BAL cells were cytocentrifuged onto slides and
stained with May-Grünwald-Giemsa solution. CD8+
cells were detected using immunocytochemistry (R&
D Systems, MN, USA). To determine cytokine con-
centrations, we centrifuged samples at 1,200 rpm for
5 min at 4℃. Supernatants were analyzed by specific
ELISA to determine the concentrations of TNF-α,
IFN-γ (BD, NJ, USA), AmotL1 (Cusabio Biotech,
Hubei, China), and VEGF (RayBiotech, GA, USA),
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and with commercially available kits.
MICROARRAY ANALYSIS
The expression of RNA from the whole lungs that
were obtained from the CS-exposed or non-exposed
mice was assessed as described previously.17 The mi-
croarray analysis revealed that the mRNA expression
of AmotL1, which is relevant to angiogenesis, de-
creased in response to CS compared with no expo-
sure to CS.
IMMUNOHISTOCHEMISTRY
Immunolocalization of AmotL1 in the lung tissue was
evaluated using polyclonal anti-AmotL1 (Assay
Biotechnology, CA, USA). AmotL1 was detected by
diaminobenzidine, and the sections were counter-
stained with hematoxylin. Negative control experi-
ments were conducted by replacing the primary anti-
body with an isotype-matched control. All of the cells
from the individual lung specimens were analyzed us-
ing an Olympus DP 70 system (Olympus, Tokyo, Ja-
pan). The results are expressed as the mean number
of AmotL1-positive vessels in 5 randomly selected
fields of tissue sections ± SE per mouse lung. We
then examined the correlation between the mean lin-
ear intercept and the AmotL1-stained vessels in the
tissue sections derived from the CS-exposed mice (n
= 11).
SUBJECTS
This study was also approved by the Iwate Medical
University Hospital Ethics Committee. Informed con-
sent was obtained from the subjects. Lung tissue
samples from ex-smoker controls (control, n = 5), ex-
smokers with bronchial asthma (n = 5), and moderate
COPD (GOLD 2) patients (n = 5) were obtained by
surgical resection for lung cancer. The control and
asthmatic subjects were matched by age to the
COPD subjects. All of the subjects had >20 pack-year
histories. The bronchial asthma and COPD subjects
were selected using the American Thoracic Society
criteria, and these individuals used an inhaled β-
agonist on demand, as well as an inhaled long-acting
β2-agonist (LABA) and inhaled corticosteroids (ICS)
twice per day. None of the patients had previously
used any other anti-inflammatory drugs, such as leu-
kotriene modifiers, or sodium cromoglicate within
the previous 3 months. Furthermore, these patients
had no other medical disorders. Five-micrometer tis-
sue sections were affixed to microscope slides and
prepared for analysis. Immunolocalization of AmotL1
in the lung tissue was performed using polyclonal
anti-AmotL1 (Assay Biotechnology). The individual
results were expressed as the mean number of
AmotL1-positive vessels in 20 randomly selected
fields of tissue sections ± SE.
IMMUNOBLOT ANALYSIS OF AmotL1 IN HUMAN
LUNG MICROVASCULAR ENDOTHELIAL CELLS
Normal human lung microvascular endothelial cells
(HLMVECs) were purchased from Takara (Tokyo,
Japan) and maintained in an EGM-2-MV BulletKit
(Takara) according to the manufacturer’s instruc-
tions. The HLMVECs that were treated with or with-
out 100 ngmL TNF-α (R&D Systems) or IFN-γ (R&
D Systems) were collected and lysed in TNE buffer,
as previously described.18 Twenty micrograms of pro-
tein was resolved by 10% SDS-PAGE and transferred
to a polyvinylidene difluoride membrane (Bio-Rad,
CA, USA). The membrane was incubated with a rab-
bit polyclonal anti-human AmotL1 (Sigma-Aldrich,
MO, USA) or a GAPDH (R&D Systems) antibody,
which was detected using an infrared detection
method (LI-COR, NE, USA) according to the manu-
facturer’s instructions. The membranes were ana-
lyzed using the Odyssey Infrared Imaging System
(LI-COR), and where relevant, the signal intensity
was determined using LI-COR imaging software and
exported to JMP version 8.0.2 (SAS Institute Japan,
Tokyo, Japan) for graphical representation as the
mean ± SE.
PREPARATION OF CELL LYSATES AND
PROBES FOR THE ELECTROPHORETIC MOBIL-
ITY SHIFT ASSAY (EMSA)
Because the putative AmotL1 promoter in HLMVECs
has not been identified, we searched for binding sites
within the AmotL1 promoter region using the UCSC
Genome Browser and TRANSFAC database.19 This
approach revealed NFκB elements that were regu-
lated by TNF-α in the AmotL1 promoter region.
HLMVECs that were pretreated with or without TGF-
β (negative control) or IFN-γ were stimulated with
100 ngmL TNF-α for 0.5 h. Nuclear extracts were
prepared from the HLMVECs as previously de-
scribed.18 A protein assay (Bio-Rad) was performed
to determine the nuclear protein concentration. Com-
plimentary oligonucleotides (5’-AGTGGAATTTCCAG
GTAGA-3’ and 5’-CCTGGAAATTCCACTTAAG-3’)
containing NFκB binding sites in the human AmotL1
promoter region with four-base overhangs were com-
bined, boiled in 0.5 M NaCl, and cooled to room tem-
perature. Mutated NFκB -binding sites (5’-AGTGTGT
ATACCAGGTAGA-3’ and 5’-CCTGGTATACACACTT
AAG-3’) were used as a negative control. Note that
the underlining identifies the mutated sequences.
The oligonucleotides were end-labeled with an infra-
red fluorophore (Metabion International, Mar-
tinsried, Germany). Probe oligonucleotides contain-
ing GATA-1-binding sites (5’-ACTCAGGCAGATAAC
AG -3’ and 5’-CAGGCTGTTATCTGCCT -3’), mutated
GATA-1-binding sites (5’-ACTCACAGGTAGACAAG-
3’ and 5’-CAGGCTTGTCTACCTGT -3’), containing
Stat-5- binding sites (5’-TTATGGCCAGAAG GATG T
ACGGTTCTGCG AAC-3’ and 5’-ATGTGTTCG CAGA
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ACCGTACATCCTCTGGCC-3’), and mutated Stat-5-
binding sites (5’-TTATGCAGCAGAGTGGACGTACT
TGAA CGTGC-3’ and 5’-ATGTGCACGTTCAAGTAC
GTCCACTCTGCTGC-3’) were also used. Ten micro-
grams of the nuclear extracts and IRD700-labeled
double-strand oligomers were incubated in binding
buffer (20% glycerol, 20 mM HEPES, 100 mM KCl, 20
mM Tris-HCl, 1 mM EDTA, and 1 mM DTT), with or
without unlabeled competitors, for 30 min at room
temperature. After a 30-min pre-run of the gel, the
samples were loaded onto 7.5% native polyacrylamide
gels in 0.25× Tris-borate-EDTA buffer and run at 120
V for 3 h at 4℃. The gels were visualized under infra-
red light. The membranes were analyzed using the
Odyssey Infrared Imaging System (LI-COR), and
where relevant, the signal intensity was determined
using LI-COR imaging software and exported to JMP
version 8.0.2 (SAS Institute Japan) for graphical rep-
resentation as the mean ± SE.
KNOCKDOWN OF p65 AND AmotL1 EXPRES-
SION USING SHORT HAIRPIN RNA
Short hairpin (sh) RNA oligonucleotides for the
NFκB p65 plasmid was purchased from Santa Cruz
Biotechnology (CA, USA). The plasmid was a target-
specific lentiviral vector engineered for knockdown
gene expression. For the shRNA delivery, 2 × 105
HLMVECs were plated in 6-well plates 2 days prior to
the transfection. The cells were transfected with
shRNA Plasmid Transfection Regent (Santa Cruz
Biotechnology), following the manufacturer’s instruc-
tions, and were then stimulated with TNF-α at 24 h
post-transfection. The control plasmid was a
transfection-ready lentiviral vector that encoded GFP
in mammalian cells and was employed to monitor the
delivery of the shRNA lentiviral construct into the
cells, thereby gauging the transfection efficiency. The
maximum transfection efficiency was observed at 16
h post-transfection.
IκBα EXPRESSION IN CYTOPLASMIC EX-
TRACTS
To determine the effect of the IFN-γ on IκBα expres-
sion, cytoplasmic extracts were prepared from 2 × 106
HLMVECsml treated with 100 ngmL IFN-γ for 72 h
and then treated with 100 ngmL TNF-α for different
time periods. Cytoplasmic extracts were prepared
from cultured HLMVECs as described previously.18
The extracts were resolved with 10% SDS-PAGE and
analyzed with immunoblotting using antibodies
against IκBα (R&D Systems). After electrophoresis,
the proteins were detected by an infrared detection
method (LI-COR, NE, USA) according to the manu-
facturer’s instructions.
STATISTICAL ANALYSIS
All of the data are expressed as the mean ± SE. The
number of cells in the BAL and the AmotL1- positive
vessels in lung tissues from air-exposed mice and CS-
exposed mice were compared using the unpaired Stu-
dent’s t test. The correlation between the linear inter-
cept and the number of AmotL1-positive vessels was
performed using correlation analysis. One-way
ANOVA was used to assess the differences among
three or four groups. JMP version 8.0.2 software
(SAS Institute Japan) was used for the statistical
analyses. Differences with p values < 0.05 were con-
sidered statistically significant.
RESULTS
DEVELOPMENT OF EMPHYSEMA IN Nrf2−−
MOUSE LUNGS AS DETERMINED IN HISTO-
LOGICAL AND INFLAMMATORY CELL STUDIES
We first evaluated the development of emphysema in
Nrf2−− mice after up to 4 weeks of CS exposure using
HE-stained lung sections. No pathological findings
were observed in the Nrf2−− mice before or after 4
weeks of air exposure (Fig. 1a-c). In the Nrf2−− mice,
airspace enlargement and alveolar wall obstruction
were both observed 4 weeks after the initial CS expo-
sure (Fig. 1d). To further characterize the develop-
ment of emphysema in the Nrf2−− mice, we deter-
mined the degree of airspace enlargement by meas-
uring the mean linear intercept in 36 randomly se-
lected fields. The mean linear intercept values in the
Nrf2−− mice were approximately 3-times higher than
the values found in the control Nrf2−− mice 4 weeks
after treatment (p < 0.01) (Fig. 1e). This histological
evaluation demonstrated that the Nrf2−− mice devel-
oped emphysema. Exposure to CS increased the ab-
solute numbers of total cells (Fig. 1f), alveolar macro-
phages (Fig. 1g), neutrophils (Fig. 1h), and CD 8-
positive T lymphocytes (Fig. 1i) in the BAL fluid of
mice, compared with air-exposed mice (p < 0.01).
EFFECTS OF CS EXPOSURE ON THE VASCU-
LAR GENE EXPRESSION PROFILES OF Nrf2−−
MICE, AS MEASURED BY cDNA MICROARRAY
AND IMMUNOHISTOCHEMISTRY
The tissue hypovascularity that was observed in the
emphysema patients suggested that the vasculature
strongly responded to the CS, resulting in emphy-
sema. To test this idea, we compared the mRNA ex-
pression between the CS-exposed and control Nrf2−−
mice by microarray analysis. The AmotL1 mRNA ex-
pression in the lung decreased in response to the CS -
exposure compared with the control Nrf2−− mice
(Table 1). AmotL1 mRNA expression was decreased
in the lungs of the CS-exposed Nrf2−− mice to a value
that was 10% below that of the air-exposed Nrf2−−
mice. We next confirmed the protein levels of
AmotL1 in the BAL fluid recovered from the mice.
We also measured the concentration of another angi-
ogenic factor, VEGF, and proinflammatory cytokines
that are implicated in emphysema, specifically TNF-α
and IFN-γ, in BAL fluid. As expected in this model,
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Fig.　1　Cigarette smoke (CS) exposure induced emphysema and increased bronchoalveolar lavage (BAL) cells in the mice. 
Shown are the hematoxylin and eosin stains of lung tissue sections (40×) from the Nrf2−/− mice before either a) air or b) CS expo-
sure and 4 weeks after c) air or d) CS exposure. Sections from the air-exposed Nrf2−/− mice exhibited normal alveolar structure (n = 
11 per group). Lung sections from the CS-exposed Nrf2−/− mice exhibited increased air space enlargement compared with the lung 
sections from the air-exposed Nrf2−/− mice. Scale bar: 100 μm. e) The mean values of the linear intercept in the cigarette smoke-
exposed Nrf2−/− mice were signifi cantly greater than those values from the air-exposed Nrf2−/− mice. The values are expressed as 
the means ± SE from 36 images per lung section. f) Total cell counts, g) macrophages, and h) neutrophils were calculated on cyto-
spin slides. i) CD8+ T cells were enumerated by immunocytochemical analysis. *indicates p < 0.01 vs. the air-exposed mice.
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Table　1　Summary of cigarette smoke-induced emphysema
associated genes identifi ed by microarray analyses
Gene name Gene accession number Expression ratio
Clca3 NM_017474 0.0495
AmotL1 NM_001081395 0.0744
B4galnt4 NM_177897 0.137
Srcrb4d NM_001160366 0.1483
Slc16a4 NM_146136 0.1558
Olfr782 NM_001011797 0.1655
Celsr3 NM_080437 0.1678
Clec12b NM_027709 0.1780
Nr1d1 NM_145434 0.1805
Cpne5 NM_153166 0.1829
Col24a1 NM_027770 0.190
Ppbp NM_023785 0.1908
Ccl24 NM_019577 0.2106
CD209a NM_133238 0.2187
Gp9 NM_018762 0.2212
Gm129 NM_001033302 0.2256
the BAL fluid concentrations of AmotL1 (Fig. 2a) and
VEGF (Fig. 2b) were markedly decreased in CS-
exposed mice compared to air-exposed mice. The lev-
els of the proinflammatory cytokines, TNF-α and
IFN-γ, in the BAL fluid from CS-exposed mice were
significantly higher than those from air-exposed mice
(not shown). To clarify which cell types express
AmotL1, the lungs were immunostained with anti-
AmotL1 antibody. In the control mice, the endothelial
cells were strongly stained with AmotL1 4 weeks af-
ter air exposure (Fig. 2c). In contrast, only a few cells
that were positively stained with the AmotL1 antibody
were observed in the lungs of the Nrf2−− mice that
were exposed to CS (Fig. 2d). Compared with lung
specimens from air-exposed mice, the number of ves-
sels expressing AmotL1 protein was significantly de-
creased in specimens from CS-exposed mice (p <
0.05) (Fig. 2e). We examined the relationship be-
tween the linear intercept and the number of AmotL1-
positive vessels in CS-exposed mice. The linear inter-
cept was inversely correlated with AmotL1 expres-
sion in the lung vessels (r = -0.77; p < 0.01) (Fig. 2f).
IMMUNOHISTOCHEMISTRY OF AmotL1 EX-
PRESSION IN THE LUNGS OF PATIENTS
AmotL1 expression was examined in the lungs ob-
tained from the control, bronchial asthmatic, and em-
physema subjects. The AmotL1-positive cells were lo-
calized to the endothelial cells and alveolar macro-
phages. As shown in Figure 3a-c, AmotL1-positive
cells were detected in all of the patient groups. The
AmotL1 protein levels of the vessels were signifi-
cantly lower in the emphysema patients compared
with the control and asthmatic patients (p < 0.05)
(Fig. 3d).
IFN-γ SUPPRESSES TNF-α-INDUCED AmotL1
EXPRESSION
HLMVECs were treated with 100 ngml IFN-γ for 72
h and then stimulated with TNF-α for 24 h, 48 h, and
72 h and examined for AmotL1 expression by im-
munoblotting. As shown in Figure 4, TNF-α induced
a 3-fold increase in AmotL1, and the IFN-γ pretreat-
ment diminished the TNF-α-induced AmotL1 expres-
sion. IFN-γ alone did not induce AmotL1 protein ex-
pression in the HLMVECs.
TNF-α INCREASES NFκB BINDING ACTIVITY AT
THE AmotL1 PROMOTER REGION
EMSA was performed to examine the AmotL1-
binding activity in the HLMVECs that were treated
with TNF-α for 0.5 h (Fig. 5a, b). Nuclear extract in-
duction from the HLMVECs with double-strand oli-
gonucleotides contained the NFκB binding site but
not the GATA-1 or Stat-5 binding sites (data not
shown) in the human AmotL1 promoter regions that
yielded mobility-shifted complexes. An excess of un-
labeled specific competitor abolished binding to the
labeled oligonucleotides and NFκB complexes,
whereas 10- and 20-fold molar excesses of the mutant
competitor oligonucleotide had no effect on the
NFκB binding activity. These data suggest that NFκB
might contribute to AmotL1 up-regulation in
HLMVECs exposed to TNF-α.
IFN-γ INHIBITS TNF-α-INDUCED NFκB ACTIVA-
TION
IFN-γ also potentially helps to regulate emphysema
pathophysiology and immunomodulation. HLMVECs
were treated with 100 ngml IFN-γ for 72 h and then
treated with 100 ngml TNF-α for 0.5 h and examined
for NFκB activation by EMSA. TNF-α activated
NFκB, and IFN-γ pretreatment abolished the TNF-α-
induced NFκB activation in a time- and dose-
dependent manner (Fig. 6a and data not shown). The
maximum suppression of NFκB activation was ob-
served when the cells were treated with 100 ngml
IFN-γ for 72 h; however, IFN-γ alone did not activate
NFκB (data not shown). In addition to TNF-α, NFκB
is also activated by a wide variety of other agents, in-
cluding IL-1, LPS, and TGF-β. The results indicated
that TGF-β did not affect the NFκB activation that
was induced by TNF-α (Fig. 6a, b).
TRANSFECTION OF HLMVECs WITH shRNA
SPECIFIC FOR NFκB p65
To further investigate the role of NFκB in the expres-
sion of AmotL1, HLMVECs were transfected with
either shRNA for NFκB p65 or control shRNA. To de-
termine the transfection efficiencies, the control plas-
mid was also transfected with the lentiviral vector
plasmid that encodes GFP. Homogenous staining of
the cytoplasm and pronounced accumulation was
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Fig.　2　Cigarette smoke (CS) exposure suppresses AmotL1 and vascular endothelial 
growth factor (VEGF) production in the airways of mice. Bronchoalveolar lavage (BAL) fl uids 
of the mice were submitted to analysis for the expression of the indicated molecules. Con-
centrations of a) AmotL1 and b) VEGF in BAL fl uid were decreased when exposed to CS. 
Representative photomicrographs show lung tissues stained with the AmotL1 antibody. c) 
Lung sections from the air-exposed Nrf2−/− mice. d) Lung sections from the CS-exposed 
Nrf2−/− mice. (400×) Scale bar: 20 μm. e) The number of AmotL1-positive vessels in the lung 
tissue specimens from air-exposed mice and CS-exposed mice. The values are means ± 
SE from 5 randomly selected fi elds of tissue sections per mouse lung (11 air-exposed mice 
and 11 CS-exposed mice). *indicates p < 0.05 vs. the air-exposed mice. f) Correlation with 
linear intercept of AmotL1-positive vessels in the lungs from the CS-exposed mice. The val-
ues were obtained from 5 randomly selected fi elds of tissue sections per mouse lung (eleven 
CS-exposed mice). The simple correlation coefficient (r) was -0.77, p < 0.01.
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Fig.　3　Lung tissues obtained from the ex-smoker control subjects, asthmatic patients, 
and emphysema patients. Representative photomicrographs show lung specimens stained 
with an anti-AmotL1 antibody. Localization of AmotL1 with endothelial cells and macro-
phages was observed in the lungs from the a) control and b) asthmatic patients. c) Local-
ization of AmotL1 with endothelial cells was not observed in the lungs of the emphysema 
patients. (400×) Scale bar: 20 μm. d) The number of AmotL1-positive vessels in the lung 
tissue specimens from the control, asthmatic, and emphysema patients. The values are 
means ± SE from 20 images per lung section. *indicates p < 0.05 vs. the control and asth-
matic patients.
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noted after 16 h in -90% of the HLMVECs (Fig. 7a).
NFκB CONTROLS AmotL1 EXPRESSION IN THE
HLMVECs
We examined the potential of an NFκB blockade to
prevent TNF-α-induced AmotL1 protein expression in
HLMVECs. Adding TNF-α to the HLMVECs for 24 h
significantly increased the AmotL1 activity compared
with the untreated HLMVECs. To determine whether
this effect was mediated by NFκB, the HLMVECs
were transfected with an shRNA specific for NFκB. In
the presence of the NFκB shRNA, the TNF-α-
induced AmotL1 expression was reduced to baseline
levels, whereas the control shRNA did not decrease
the AmotL1 expression. Therefore, NFκB is required
for TNF-α-induced AmotL1 regulation (Fig. 7b, c).
IFN-γ INHIBITS THE TNF-α-DEPENDENT DEGRA-
DATION OF IκBα
To determine whether the TNF-α-induced NFκB acti-
vation was inhibited by inhibiting IκBα degradation,
the HLMVECs were pretreated with 100 ngmL IFN-
γ for 72 h, exposed to 100 ngml TNF-α for different
time periods, and then examined for IκBα expression
in the cytoplasm by immunoblotting. As shown in
Figure 8a, b, the TNF-α-induced IκBα degradation in
the HLMVECs reached its maximum at 60 min,
whereas the TNF-α-induced IκBα degradation was
completely suppressed in the IFN-γ-treated cells (Fig.
8c, d).
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Fig.　4　Effects of IFN-γ on TNF-α-induced AmotL1 protein expression in human 
lung microvascular endothelial cells (HLMVECs). Stimulation with TNF-α at a con-
centration of 100 ng/ml for 24 h increased the AmotL1 protein expression in 
HLMVECs. a) Data are representative of fi ve separate experiments. b) Summary 
of the data (mean ± SE) from fi ve independent experiments. *indicates p < 0.05 vs. 
TNF-α stimulation for 0 h. HLMVECs were treated with 100 ng/ml of IFN-γ for 72 h 
and then stimulated with TNF-α for 24 h. The cells were then examined for AmotL1 
expression by immunoblotting. IFN-γ pretreatment diminished the TNF-α-induced 
AmotL1 expression. IFN-γ alone did not induce AmotL1 protein expression in the 
HLMVECs. c) Data are representative of fi ve separate experiments. d) Summary 
of the data (mean ± SE) of fi ve independent experiments. *indicates p < 0.05 vs. 
the TNF-α stimulation condition.
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DISCUSSION
Several new findings have emanated from this study.
First, we demonstrated that AmotL1 expression was
significantly decreased in the lungs of the CS-
exposed mice compared with the control mice. The
AmotL1-positive cells were phenotypically identified
as endothelial cells and macrophages. Second, we
found that the number of AmotL1-positive blood ves-
sels was decreased in the emphysema patients com-
pared with the control and asthmatic patients. Third,
we determined that TNF-α increased AmotL1 expres-
sion in HLMVECs via the transcription factor NFκB.
Finally, IFN-γ suppressed TNF-α-dependent IκBα
degradation in the HLMVECs.
We elected to forgo the use of the most common
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Fig.　5　Electrophoretic mobility shift assay (EMSA) for AmotL1-binding activity. EMSA with nuclear extracts from human 
lung microvascular endothelial cells (HLMVECs) treated with or without TNF-α at 100 ng/ml for 0.5 h and incubated with 
an infrared fl uorophore, which shows double-stranded oligonucleotides containing the NFκB-binding site in the AmotL1 
promoter region. a) Competition assays with unlabeled homologues or mismatch oligonucleotides. lane 1, without TNF-α 
stimulation; lane 2, no competitor; lane 3 and lane 4, excess mismatch competitor (lane 2, 10-fold excess; lane 3, 20-fold 
excess); lane 5 and lane 6, excess unlabeled specifi c competitor (lane 5, 10-fold excess; lane 6, 20-fold excess). b) Quanti-
fi cation of the EMSA with the infrared fl uorophore-labeled AmotL1 promoter region. Summary of the data (mean ± SE) of 
fi ve independent experiments. *indicates p < 0.05 vs. the no oligo condition.
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CS-induced emphysema model, using C57BL6 J
mice, preferring to use Nrf2−− mice, which were
backcrossed into a C57BL6J background. This
choice was based on compelling data that led us to
believe that this approach would be better. However,
of particular concern with the Nrf2++ mouse is that
the need for more than 6 months of CS exposures
often results in complicating age-associated vessel
structure phenotypes. Singh et al. have demonstrated
an emphysema model using 4-weeks-CS-exposed
Nrf2−− mice.20 Although we did not assess or report
on the lung mechanics, such as the static lung com-
pliances, it was demonstrated that the BAL cells and
histological findings from 4-weeks-CS-exposed
Nrf2−− mice were in agreement with previous em-
physema mouse models. In our preliminary studies,
we could not demonstrate that there was a significant
increase of BAL cells and airspace enlargement with
variable components of angiogenic factors in the 4-
weeks-CS-exposed Nrf2++ mice. Then, we verified
the expression of molecules that the mouse model in-
dicated might be expressed in the tissues from con-
trols and patients with COPD.
There are several candidate angiogenic factors
with pathogenic roles in emphysema, the most fre-
quent of which is VEGF. Normal lung function and
the ability of the lung to respond to damage appear to
be critically dependent on the presence of locally
functioning VEGF.6,7 VEGF deficiency augments oxi-
dant injury and tissue destruction and has been impli-
cated in the pathogenesis of pulmonary emphysema
and other disorders. However, the processes that
regulate VEGF tissue responses in the lung have not
been elucidated. Recently, Elias and colleagues have
demonstrated that influenza and respiratory syncytial
virus exert similar inhibitory effects on vascular re-
modeling via the IFN-γ-dependent pathway.21,22 In
our study, using a murine model, pulmonary VEGF
protein levels were significantly decreased in CS-
exposed mice when compared with air-exposed mice.
Furthermore, the microarray and histological find-
ings indicate a possible role of AmotL1 in the patho-
genesis of emphysema. Amot is a vascular angiogene-
sis related-protein that can induce endothelial cell mi-
gration and tubule formation, thereby promoting an-
giogenesis. An isoform of AmotL1 functions as a key
regulator of endothelial cell migration and cell-cell
junction stability.12 There appeared to be a distinct
difference between the vessels that were arrested
due to VEGF23 versus amotL1 knockdown. In amotl1
The Role of TNF-α and IFN-γ in AmotL1
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Fig.　6　Effects of IFN-γ on TNF-α-induced AmotL1 DNA binding activity. Electrophoretic mobility 
shift assay (EMSA) for AmotL1 binding activity. Human lung microvascular endothelial cells (HLM-
VECs) were pretreated for 72 h with or without TGF-β (10 ng/ml) or IFN-γ (10 ng/ml or 100 ng/ml) 
and then stimulated with TNF-α (100 ng/ml) for an additional 0.5 h. a) The nuclear extracts from cul-
tured HLMVECs were assessed via EMSA. b) Quantifi cation of the EMSA with the infrared fl uoro-
phore-labeled AmotL1 promoter region. Data are the summary (mean ± SE) of fi ve independent ex-
periments. *indicates p < 0.05 vs. the no pretreatment condition.
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knockdown vessels, sprouting vessels and the
spreading of tip cells were arrested, and connections
between the stalk cells and the aorta appeared to be
destabilized. Consistent with its functions during
physiologic angiogenesis in the zebrafish model of
blood vessel development, it is tempting to speculate
that amotl1 knockdown mice might have an enlarged
airspace of the lungs accompanying the decrease of
angiogenic potential. We believe that this response is
linked to the cell-cell junction control of the stalk
cells, which play striking and distinct roles when
compared to down regulated VEGF-induced patho-
genesis in developing emphysema.
Based on our present in vivo study, we employed
in vitro cultures of HLMVECs to evaluate the effect of
cytokines on AmotL1 expression. IFN-γ levels are
lower in the sputa of patients with stable emphysema
compared with patients who have exacerbations of
emphysema, which is also associated with viral infec-
tions.24 IFN-γ also acts as an anti-angiogenic cytokine
and decreases the expression of connective tissue
growth factor (CTGF), which induces angiogenesis
and regulates endothelial cell function. Moreover,
TNF-α interacts in a synergistic fashion with IFN-γ to
diminish CTGF expression in lung endothelial cells.25
Our study demonstrated, unexpectedly, that TNF-α
induces the expression of AmtoL1, which is sup-
pressed by IFN-γ. TNF-α is a major inflammatory me-
diator that induces multiple changes in endothelial
cell gene expression, including adhesion molecules,
integrins, and matrix metalloproteinases. However,
its effects on angiogenesis have been the subject of
controversy. Angiogenesis is a multistep process that
involves endothelial cell degradation of the adjacent
basement membrane, sprouting, proliferation, align-
ment, tube formation, branching, anastomosis, the
synthesis of new basement membranes, the recruit-
ment of parenchymal cells, and a return to quies-
cence.26-29 It is possible that TNF-α differentially af-
fects each of these steps. In fact, additional studies
have demonstrated that TNF-α primes endothelial
cells for angiogenic sprouting by inducing a tip-cell
phenotype through NFκB activation.30,31
In the present study, EMSAs were performed to
determine whether NFκB interacts with the AmotL1
promoter region. To date, it has been demonstrated
that there might be multiple transcription-factor-
binding sites in the AmotL1 promoter region, but
whether they play a critical role in regulating AmotL1
expression in HLMVECs is unknown. All of the
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Fig.　7　Generation of stable NFκB-silenced human lung mi-
crovascular endothelial cells (HLMVECs) and the effects of 
NFκB p65 shRNA on TNF-α-induced AmotL1 expression. 
The selection of stable lines of cell containing the lentiviral-
transduced shRNA was accomplished via puromycin selection. 
NFκB is required for TNF-α-induced AmotL1 regulation. a) 
HLMVECs could be effectively transfected with control plasmids. 
The transfection efficiency was observed by immunofl uores-
cence confocal microscopy. b) HLMVECs were pretreated for 
16 h with or without shRNA and then stimulated with TNF-α 
(100 ng/ml) for an additional 24 h. The cellular extracts were 
immunoblotted for AmotL1 and GAPDH. c) The densitometric 
analysis of AmotL1 production. Data are expressed as the 
mean ± SE of fi ve independent experiments. *indicates p < 0.05 
vs. TNF-α stimulation (100 ng/ml) without shRNA. -, without 
shRNA; C, control shRNA; N, NFκB shRNA.
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known AmotL1 sequences were searched for the
presence of putative transcription-factor-binding ele-
ments using the TRANSFAC database.19 Based on
the data, the GATA-1-binding site (-573-583), the
Stat-5A-binding site (-557-533) and the NFκB-
binding site (-384-372) contain activating elements.
In the present study, we observed that the major pro-
moter region in which NFκB mainly regulates tran-
scription is by binding to the -384 to -372 segment. To
confirm the role of NFκB in regulating AmotL1 ex-
pression, we transfected HLMVECs with shRNA. Our
studies demonstrated that NFκB is necessary for
AmotL1 expression in HLMVECs and that IFN-γ in-
teracts at the transcription level with IκBα to reduce
AmotL1 expression. Some reports have indicated the
ability of IFN-α or IFN-γ to inhibit TNF-α-induced
NFκB pathways in various cell types.32-35 Multiple
mechanisms underlying the IFN inhibitory effect on
the NFκB pathways have been discussed, including
the following mechanisms: 1) preventing IκB degra-
dation33; 2) inhibiting the NFκB-DNA interaction34;
and 3) tightly regulating the TNF-α receptor 1 activ-
ity induced by its direct interaction with Stat1 (acti-
vated by interferons).36,37 In our present study, IFN-γ
prevented the degradation of IκBα in HLMVECs, and
it is conceivable that IFN-γ regulated the TNF-α-
induced AmotL1-dependent angiogenesis.
When viewed in combination, our data suggest that
TNF-α and IFN-γ are expressed in the airways of
mice exposed to CS and that the IFN-γ-mediated-
prevention of IκBα degradation contributes to the
pathogenesis of pulmonary emphysema, at least in
part, via its ability to induce the sprouting tip cells of
pulmonary structural vessels. It is also likely that the
IFN-γ level, which is influenced by viral infections, lo-
cally affects signals in the developing vessels. Further
examination is necessary to clarify the mechanisms
that mediate anti-viral innate immune responses in
the pathogenesis caused by decreased AmotL1 levels
in the emphysema lung.
The lung tissues from the patients with bronchial
asthma and emphysema were all treated with LABA
and ICS. Because studies from our laboratory have
demonstrated that there were no significant differ-
ences in the AmotL1 expression in asthmatic lungs
treated with ICS and without ICS (unpublished data),
we speculated that this ICS-AmotL1 interaction did
not affect the expression of AmotL1 in the lungs.
However, it has been reported that both progester-
one and estrogen steroids are upregulators of
AmotL1 expression.38 Additional investigation will be
required to define the mechanisms of the TNF-α and
IFN-γ interaction in the HLMVECs under steroid
treatment.
Taken together, our data highlight the importance
of AmotL1 in the pathogenesis of emphysema; fur-
thermore, we have identified the precise molecular
mechanisms that may assist in furthering our under-
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Fig.　8　The effects of IFN-γ on TNF-α-dependent degradation of IκBα. Human lung micro-
vascular endothelial cells (HLMVECs) pretreated with or without 100 ng/ml IFN-γ for 72 h 
were stimulated with 100 ng/ml TNF-α for the indicated times. The cytosolic fractions were 
then analyzed by immunoblotting using IκBα and GAPDH antibodies. IFN-γ blocks the TNF-
α-induced degradation of IκBα. a, c) Representative of fi ve separate experiments. b, d) 
Summary of the data (mean ± SE) of fi ve independent experiments. *indicates p < 0.05 vs. 
stimulation for 0 min.
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standing of the pathology of emphysema.
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